Shots: BioVectra to provide its integrated CDMO services for the manufacturing of API of bentracimab for use in PhaseBio’s ongoing global studies and global commercial use upon regulatory approval PhaseBio […]readmore
Tags : BioVectra
Shots: H.I.G. Capital acquires BioVectra (a subsidiary of Mallinckrodt) for $175M fixed consideration including $135M as up front and $40M as long term note along with a contingent payment of […]readmore